21.01
price down icon0.10%   -0.02
after-market Dopo l'orario di chiusura: 21.01
loading
Precedente Chiudi:
$21.03
Aprire:
$21.12
Volume 24 ore:
1.05M
Relative Volume:
0.88
Capitalizzazione di mercato:
$2.56B
Reddito:
$460.48M
Utile/perdita netta:
$142.80M
Rapporto P/E:
17.81
EPS:
1.18
Flusso di cassa netto:
$221.79M
1 W Prestazione:
-2.82%
1M Prestazione:
-6.54%
6M Prestazione:
-8.33%
1 anno Prestazione:
+24.03%
Intervallo 1D:
Value
$20.95
$21.42
Intervallo di 1 settimana:
Value
$20.60
$21.78
Portata 52W:
Value
$15.34
$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Name
Nome
Catalyst Pharmaceuticals Inc
Name
Telefono
(305) 529-2522
Name
Indirizzo
355 ALHAMBRA CIRCLE, CORAL GABLES
Name
Dipendente
167
Name
Cinguettio
@CatalystForRare
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
CPRX's Discussions on Twitter

Confronta CPRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CPRX
Catalyst Pharmaceuticals Inc
21.01 2.64B 460.48M 142.80M 221.79M 1.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-04 Iniziato Robert W. Baird Outperform
2024-11-18 Iniziato Stephens Overweight
2024-03-14 Iniziato Citigroup Buy
2024-03-07 Iniziato BofA Securities Buy
2023-12-21 Iniziato Oppenheimer Outperform
2022-08-24 Downgrade ROTH Capital Buy → Neutral
2018-09-21 Iniziato Cantor Fitzgerald Overweight
2018-09-07 Ripresa Piper Jaffray Overweight
2016-10-05 Aggiornamento Piper Jaffray Neutral → Overweight
2016-04-26 Downgrade Piper Jaffray Overweight → Neutral
2014-09-30 Reiterato ROTH Capital Buy
2014-09-16 Reiterato ROTH Capital Buy
2014-09-15 Reiterato H.C. Wainwright Buy
2013-10-21 Reiterato Aegis Capital Buy
2013-09-24 Iniziato Maxim Group Buy
2013-09-06 Reiterato Aegis Capital Buy
2013-04-18 Iniziato Aegis Capital Buy
2012-08-27 Aggiornamento Rodman & Renshaw Mkt Perform → Mkt Outperform
2009-10-01 Aggiornamento Merriman Sell → Neutral
2009-05-29 Downgrade Hapoalim Neutral → Underperform
2009-05-29 Downgrade Merriman Curhan Ford Buy → Sell
2008-12-15 Iniziato Merriman Curhan Ford Buy
2007-11-28 Iniziato Rodman & Renshaw Mkt Outperform
2007-01-31 Iniziato Stifel Nicolaus Buy
2007-01-05 Iniziato First Albany Buy
Mostra tutto

Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie

pulisher
09:40 AM

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

09:40 AM
pulisher
Jul 20, 2025

What drives Catalyst Pharmaceuticals Inc. stock priceHigh-octane financial growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Catalyst Pharmaceuticals Inc. stockOverwhelming financial success - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Catalyst Pharmaceuticals Inc. a good long term investmentLightning-fast growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Catalyst Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit margins - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Why Catalyst Pharmaceuticals Inc. stock is on top investor watchlistsSafe and Smart Investment Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Published on: 2025-07-17 22:44:23 - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo

Jul 17, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail

Jul 17, 2025
pulisher
Jul 16, 2025

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo.co

Jul 16, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Sells 2,766 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Catalyst Pharmaceuticals Inc. stock price move sharplyFree Stock Tips Group - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Catalyst Pharmaceuticals Inc. stock attracts strong analyst attentionPro Trader Stock Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Catalyst Pharmaceuticals Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Principal Financial Group Inc. Purchases 17,018 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 12, 2025
pulisher
Jul 10, 2025

Amalgamated Bank Decreases Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Cambridge Investment Research Advisors Inc. Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

GAMMA Investing LLC Acquires 579 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 09, 2025
pulisher
Jul 08, 2025

Institutional investors in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) lost 3.5% last week but have reaped the benefits of longer-term growth - simplywall.st

Jul 08, 2025
pulisher
Jul 08, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by New York State Teachers Retirement System - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jul 07, 2025
pulisher
Jul 07, 2025

Allspring Global Investments Holdings LLC Sells 244,148 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 07, 2025
pulisher
Jul 04, 2025

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance

Jul 04, 2025
pulisher
Jul 01, 2025

Catalyst Pharmaceuticals is Now Oversold (CPRX) - Nasdaq

Jul 01, 2025
pulisher
Jun 26, 2025

Top 3 Health Care Stocks You'll Regret Missing This Quarter - inkl

Jun 26, 2025
pulisher
Jun 19, 2025

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Nasdaq

Jun 19, 2025
pulisher
Jun 18, 2025

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth - Yahoo Finance

Jun 18, 2025
pulisher
Jun 16, 2025

Stanley Laman Group Ltd. Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Jun 16, 2025
pulisher
Jun 15, 2025

GAMMA Investing LLC Has $1.64 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Catalyst Pharmaceuticals (NASDAQ:CPRX) Trading Down 5.2% Following Insider Selling - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells $42,272.00 in Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Trading (CPRX) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 13, 2025

Preethi Sundaram Implements A Sell Strategy: Offloads $103K In Catalyst Pharmaceuticals Stock - Nasdaq

Jun 13, 2025
pulisher
Jun 12, 2025

Insider Sell: Preethi Sundaram Sells Shares of Catalyst Pharmaceuticals Inc (CPRX) - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Preethi Sundaram Sells 2,324 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

117,374 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Bought by Bridge City Capital LLC - MarketBeat

Jun 12, 2025
pulisher
Jun 11, 2025

Director Of Catalyst Pharmaceuticals Sold $5.22M In Stock - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Strong Inflows Make Catalyst Stock an Outlier - FXEmpire

Jun 11, 2025
pulisher
Jun 10, 2025

Insider Sell: Patrick Mcenany Sells 200,000 Shares of Catalyst P - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Jun 10, 2025
pulisher
Jun 09, 2025

Catalyst Pharmaceuticals stock soars to all-time high of $26.49 By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Catalyst Pharmaceuticals stock soars to all-time high of $26.49 - Investing.com Australia

Jun 09, 2025

Catalyst Pharmaceuticals Inc Azioni (CPRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):